The historic rise of Viagra has firmly established as a benchmark of pharmaceutical success, but its legacy within the broader industry now raises questions about future returns . Alternative versions are diminishing exclusivity , prompting anxieties that supporting companies heavily reliant to Viagra's former standing could be a problematic decisi